Gene · 9869
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
| Comprehensive review of tujia "Lian" medicinal botanical drugs: traditional classification system, phytochemical, and pharmacological profile. | Front Pharmacol | 2026 | 41788811 | PubTator, text mining | PubMed |
| A de novo H3.2K9me2 deposition pathway establishes heterochromatin for suppressing transposon mobilization during fly somatic development. | Nucleic Acids Res | 2026 | 41755642 | PubTator, text mining | PubMed |
| Nuclear and Mitochondrial Epigenetic Mechanisms Underlying Neurodegeneration and Gut-Brain Axis Dysregulation Induced by Micro- and Nanoplastics. | Genes (Basel) | 2026 | 41751535 | PubTator, text mining | PubMed |
| OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer. | Cell Death Dis | 2026 | 41730840 | PubTator, text mining | PubMed |
| Mechanisms at the Intersection of lncRNA and m6A Biology. | Noncoding RNA | 2026 | 41718093 | PubTator, text mining | PubMed |
| Ubiquitination at pericentromeric regions: directing heterochromatin reassembly during cell division. | Signal Transduct Target Ther | 2026 | 41714594 | PubTator, text mining | PubMed |
| SETDB1 enables development beyond cleavage stages by extinguishing the MERVL-driven two-cell totipotency transcriptional program in the mouse embryo. | Elife | 2026 | 41697236 | PubTator, text mining | PubMed |
| ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer. | Cancer Res | 2026 | 41661654 | PubTator, text mining | PubMed |
| SETDB1/ATF7IP regulate the precise genome engineering of HUSH-regulated genes. | Epigenetics Chromatin | 2026 | 41656257 | PubTator, text mining | PubMed |
| Loss of SETDB1-mediated H3K9me3 in human neural progenitor cells leads to transcriptional activation of L1 retrotransposons. | Nucleic Acids Res | 2026 | 41641702 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Roles of TIF1β in Leukemic Stem Cell Through SETDB1-Dependent and Independent Mechanisms. | Cancer Sci | 2026 | 41601208 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| The X Factor in Immunity: Sex Differences Shaped by the X Chromosome. | Immunol Rev | 2026 | 41574968 | PubTator, text mining | PubMed |
| A PNPLA3-NACC1-RIPK3 pathway mediates macrophage necroptosis and inflammation in MASLD. | Hepatol Commun | 2026 | 41564367 | PubTator, text mining | PubMed |
| Cell density-dependent nuclear-cytoplasmic shuttling of SETDB1 integrates with Hippo signaling to regulate YAP1-mediated transcription. | FEBS Lett | 2026 | 41553709 | PubTator, text mining | PubMed |
| Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production. | MAbs | 2026 | 41548093 | PubTator, text mining | PubMed |
| Luteolin Isolated from Cuscuta Chinensis Lam Inhibits Lung Cancer Cell Viability and Migration via Co-Treatment with Mithramycin A. | Curr Cancer Drug Targets | 2026 | 41540539 | PubTator, text mining | PubMed |
| The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer. | Cell Oncol (Dordr) | 2026 | 41493679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9869/papers?page=3